Inaugural Dr Janina Hopkin Medical Lecture: Fifty Years on from Thalidomide

Please note, this page has been archived and is no longer being updated.

St David’s Medical Foundation, in partnership with Swansea University’s College of Medicine, is to host the inaugural Dr Janina Hopkin Medical Lecture.

St David’s Medical Foundation, in partnership with Swansea University’s College of Medicine, is to host the inaugural Dr Janina Hopkin Medical Lecture.

Lecture title: Fifty years on from thalidomide - what's new in birth defects?

Speaker: Dr Patricia Boyd of the National Perinatal Epidemiology Unit at Oxford University

Date: Tuesday 23rd September 2014

Time: 5.30pm followed by refreshments at 6:30pm

Venue: Grove Lecture Theatre, Grove Building, College of Medicine, Swansea University

Admission: Free of charge, all welcome

For more information email: medmarketing@swansea.ac.uk

Dr Patricia Boyd studied Medicine at University College London and went on to specialise and work in the areas of fetal and placental pathology, clinical genetics and prenatal diagnosis.

From 1992 to 2007, she was clinical geneticist for prenatal diagnosis in Oxford. In 1991 she established the congenital anomaly register in Oxford and went on to contribute prominently to BINOCAR (British Isles Network of Congenital Anomaly Registers) and to EUROCAT (European Surveillance of Congenital Anomalies).

From 2007 to 2013, she was based at the National Perinatal Epidemiology Unit at the University of Oxford and was President of EUROCAT from 2008 to 2010.  She has studied, in particular, the effectiveness of different prenatal screening policies on clinical practice and outcomes.